Published in J Virol on September 01, 1989
Functional interactions between the fusion protein and hemagglutinin-neuraminidase of human parainfluenza viruses. J Virol (1992) 3.20
Functional interaction of paramyxovirus glycoproteins: identification of a domain in Sendai virus HN which promotes cell fusion. J Virol (1996) 2.63
Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol (1992) 2.47
Analysis of the contributions of herpes simplex virus type 1 membrane proteins to the induction of cell-cell fusion. J Virol (1994) 2.17
Fusion properties of cells persistently infected with human parainfluenza virus type 3: participation of hemagglutinin-neuraminidase in membrane fusion. J Virol (1991) 2.02
Complementation between avirulent Newcastle disease virus and a fusion protein gene expressed from a retrovirus vector: requirements for membrane fusion. J Virol (1991) 1.91
Quantitative measurement of paramyxovirus fusion: differences in requirements of glycoproteins between simian virus 5 and human parainfluenza virus 3 or Newcastle disease virus. J Virol (1995) 1.89
Fusion properties of cells infected with human parainfluenza virus type 3: receptor requirements for viral spread and virus-mediated membrane fusion. J Virol (1992) 1.53
Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology (2008) 1.40
Influence of the human parainfluenza virus 3 attachment protein's neuraminidase activity on its capacity to activate the fusion protein. J Virol (2005) 1.36
The hemagglutinin envelope protein of canine distemper virus (CDV) confers cell tropism as illustrated by CDV and measles virus complementation analysis. J Virol (1995) 1.18
Fusion mutants of Newcastle disease virus selected with monoclonal antibodies to the hemagglutinin-neuraminidase. J Virol (1992) 1.15
Hemagglutinin-neuraminidase enhances F protein-mediated membrane fusion of reconstituted Sendai virus envelopes with cells. J Virol (1993) 1.05
Comparisons of the F and HN gene sequences of different strains of bovine parainfluenza virus type 3: relationship to phenotype and pathogenicity. Can J Vet Res (1996) 0.80
A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector. J Virol (2003) 0.78
Identification of an amino acid that defines the fusogenicity of mumps virus. J Virol (1993) 0.76
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
New M13 vectors for cloning. Methods Enzymol (1983) 90.74
"Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem (1981) 71.15
Analysis of the accuracy and implications of simple methods for predicting the secondary structure of globular proteins. J Mol Biol (1978) 33.47
High-efficiency cloning of full-length cDNA. Mol Cell Biol (1982) 22.81
A cDNA cloning vector that permits expression of cDNA inserts in mammalian cells. Mol Cell Biol (1983) 18.32
Distinctive nucleotide sequences adjacent to multiple initiation and termination sites of an early vaccinia virus gene. Cell (1981) 4.42
Two mRNAs that differ by two nontemplated nucleotides encode the amino coterminal proteins P and V of the paramyxovirus SV5. Cell (1988) 3.98
Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med (1980) 3.32
Surface expression of viral glycoproteins is polarized in epithelial cells infected with recombinant vaccinia viral vectors. EMBO J (1986) 3.00
Expression at the cell surface of biologically active fusion and hemagglutinin/neuraminidase proteins of the paramyxovirus simian virus 5 from cloned cDNA. Proc Natl Acad Sci U S A (1985) 2.56
Reconstitution of membranes with individual paramyxovirus glycoproteins and phospholipid in cholate solution. Virology (1979) 2.20
Sequence determination of the Sendai virus HN gene and its comparison to the influenza virus glycoproteins. Cell (1985) 2.01
The function of the neuraminidase in membrane fusion induced by myxoviruses. Virology (1980) 1.97
Distinct functions of antigenic sites of the HN glycoprotein of Sendai virus. Virology (1987) 1.52
Identification of amino acids relevant to three antigenic determinants on the fusion protein of Newcastle disease virus that are involved in fusion inhibition and neutralization. J Virol (1988) 1.49
Polarized expression of a chimeric protein in which the transmembrane and cytoplasmic domains of the influenza virus hemagglutinin have been replaced by those of the vesicular stomatitis virus G protein. Proc Natl Acad Sci U S A (1986) 1.37
Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34
Replacement of the cytoplasmic domain alters sorting of a viral glycoprotein in polarized cells. Proc Natl Acad Sci U S A (1987) 1.33
Conversion of nonfusing mumps virus infections to fusing infections by selective proteolysis of the HN glycoprotein. Virology (1983) 1.28
Cell surface expression and orientation in membranes of the 44-amino-acid SH protein of simian virus 5. J Virol (1988) 1.27
Biochemical features of mumps virus neuraminidases and their relationship with pathogenicity. Virology (1981) 1.27
Identification of amino acids involved in the sialidase activity of the mumps virus hemagglutinin-neuraminadase protein. Virology (1988) 1.26
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus. Infect Immun (1983) 1.12
Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteins. Virology (1988) 1.01
Experimental parainfluenzavirus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus. Infect Immun (1982) 0.94
Gene structures of low-neurovirulent vaccinia virus LC16m0, LC16m8, and their Lister original (LO) strains. Microbiol Immunol (1985) 0.91
Experimental parainfluenza virus infection in mice: growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brain. Arch Virol (1985) 0.85
Differences in bovine parainfluenza 3 virus variants studied by monoclonal antibodies against viral glycoproteins. Virology (1986) 0.80
Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P and C proteins. Nucleic Acids Res (1983) 3.62
Determination of the complete nucleotide sequence of the Sendai virus genome RNA and the predicted amino acid sequences of the F, HN and L proteins. Nucleic Acids Res (1986) 2.60
RNA packaging signal of human immunodeficiency virus type 1. Virology (1992) 2.38
Production of human immunodeficiency virus (HIV)-like particles from cells infected with recombinant vaccinia viruses carrying the gag gene of HIV. Virology (1990) 2.24
Characterization of bovine parainfluenza virus type 3. Microbiol Immunol (1979) 1.68
Nucleotide sequence of the bovine parainfluenza 3 virus genome: its 3' end and the genes of NP, P, C and M proteins. Nucleic Acids Res (1987) 1.34
Parainfluenza 3 virus: plaque-type variants lacking neuraminidase activity. Infect Immun (1981) 1.25
Rescue of Sendai virus from viral ribonucleoprotein-transfected cells by infection with recombinant vaccinia viruses carrying Sendai virus L and P/C genes. Virology (1989) 1.23
Polyadenylate in the virion RNA of mouse hepatitis virus. J Biochem (1977) 1.21
Nucleotide sequence of a Sendai virus genome region covering the entire M gene and the 3' proximal 1013 nucleotides of the F gene. Nucleic Acids Res (1984) 1.16
Neuraminidase activity and syncytial formation in variants of parainfluenza 3 virus. Infect Immun (1983) 1.12
Plaque formation by sendai virus of parainfluenza virus group, type 1 on monkey, calf kidney and chick embryo cell monolayers. Jpn J Microbiol (1971) 1.05
Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance. J Gen Virol (1987) 1.05
Syncytium formation of human and non-human cells by recombinant vaccinia viruses carrying the HIV env gene and human CD4 gene. AIDS (1991) 1.04
An improved plaque assay for varicella virus. Arch Virol (1976) 1.04
Differences in bovine parainfluenza 3 virus variants studied by sequencing of the genes of viral envelope proteins. Virology (1988) 1.01
Nucleotide sequence of the bovine parainfluenza 3 virus genome: the genes of the F and HN glycoproteins. Nucleic Acids Res (1987) 1.01
Activation of the alternative pathway of guinea pig complement by Sendai virus-treated cells. Microbiol Immunol (1979) 0.96
Experimental parainfluenzavirus infection in mice: fatal illness with atrophy of thymus and spleen in mice caused by a variant of parainfluenza 3 virus. Infect Immun (1982) 0.94
Experimental parainfluenzavirus infection. 1. Hydrocephalus of mice due to infection with parainfluenza virus type 1 and type 3. Microbiol Immunol (1978) 0.93
Varicella virus isolation from spinal ganglion. Arch Gesamte Virusforsch (1974) 0.92
The induction of cataracts by HIV-1 in transgenic mice. AIDS (1992) 0.92
Interferon induction by transfection of Sendai virus C gene cDNA. J Virol (1987) 0.91
A temperature-sensitive mutant of Sendai virus which establishes persistent infection in Vero cells without cell crisis. Virology (1981) 0.90
Antigenic variation of human and bovine parainfluenza virus type 3 strains. J Gen Virol (1990) 0.89
Effect of trypsin on the infectivity of Sendai virus grown in several host cells. Jpn J Microbiol (1972) 0.89
Transformation of tissue-cultured xeroderma pigmentosum fibroblasts by treatment with N-methyl-N'-nitro-N-nitrosoguanidine. Nature (1976) 0.88
Protein factors required for in vitro transcription of Sendai virus genome. J Biochem (1995) 0.87
Experimental parainfluenza virus infection in mice: growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brain. Arch Virol (1985) 0.85
Isolation and characterization of temperature-sensitive mutants of Sendai virus. Microbiol Immunol (1980) 0.84
Inhibitory effect of oligomycin on replication of sendai virus and a bovine enterovirus in cultured cells. Jpn J Exp Med (1971) 0.81
Differences in bovine parainfluenza 3 virus variants studied by monoclonal antibodies against viral glycoproteins. Virology (1986) 0.80
Molecular analysis of structural protein genes of the Yamagata-1 strain of defective subacute sclerosing panencephalitis virus. II. Nucleotide sequence of a cDNA corresponding to the P plus M dicistronic mRNA. Virus Genes (1990) 0.79
Enhancement of 32P incorporation into phospho- lipids in cultured cells by sendai virus of parainfluenza type 1. Jpn J Microbiol (1971) 0.78
Agar-disc neutralization test for rubella virus. Jpn J Microbiol (1973) 0.77
Incorporation of 32P into phospholipids of influenza A and parainfluenza 1 viruses. Jpn J Microbiol (1969) 0.77
Enhanced synthesis of phosphatidylethanolamine in chick embryo cells infected with Sendai virus of parainfluenza type 1. Jpn J Microbiol (1972) 0.75
Restricted viral RNA synthesis in establishment of persistent infection in Vero cells with a Sendai virus mutant. Microbiol Immunol (1982) 0.75
Lipids of Sendai virus and changes in cellular phospholipid synthesis caused by infection. Jpn J Microbiol (1971) 0.75
[Structure of paramyxovirus genome]. Uirusu (1984) 0.75
Separation of Sendai virus protein by thin layer polyacrylamide gel electrophoresis. Jpn J Exp Med (1970) 0.75
Serum protein patterns of subfraction in patients with lung cancer and lung tuberculosis. Nihon Gan Chiryo Gakkai Shi (1981) 0.75
Lyophilization of varicella virus. Brief report. Arch Gesamte Virusforsch (1973) 0.75
Immune response of mice infected with recombinant vaccinia viruses carrying the HIV gag gene. Microbiol Immunol (1991) 0.75
[Biochemical studies on experimental pulmonary fibrosis in rabbits treated with N-methyl-N-nitrosourethane (author's transl)]. Nihon Kyobu Shikkan Gakkai Zasshi (1977) 0.75